MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Brock Reeve to Present at 8th Stem Cell Summit on April 19-20 in Boston - Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute to give a Featured Presentation on “The Latest From The Lab” at the 8th Stem Cell Summit (April 19-20 in Boston, MA) - GTCbio.com
Brock Reeve to Present at 8th Stem Cell Summit on April 19-20 in Boston

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2012/02/23 - Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute to give a Featured Presentation on “The Latest From The Lab” at the 8th Stem Cell Summit (April 19-20 in Boston, MA) - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Latest From The Lab
In the current environment, the commercial sector is increasingly dependent on interactions with academia for new ideas and the latest science, especially in a field where the knowledge base is literally growing at an exponential rate. This talk will highlight some of the more recent findings in the field of stem cell science that are coming out of the leading labs of the Harvard Stem Cell Institute. Examples of stem cells in their uses as tools, as targets and as therapies will be discussed as well as examples of what we have learned as a result of knowing more about biology and disease. The implications of these findings for the clinic and the market will be highlighted.

The 8th Stem Cell Summit includes two concurrent tracks including a couple joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed.

In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?

Session Topics for each track are shown below:

Track 1: Stem Cell Research & Regenerative Medicine:
- Funding Opportunities (Joint Session);
- Regulatory Guidance & Updates (Joint Session);
- Novel Advances in Stem Cell Research;
- Advances in Regenerative Medicine and Tissue Engineering;
- Overcoming Challenges in Clinical Development;
- Bringing Research to Drug Discovery.

Track 2: Stem Cell Commercialization & Partnering:
- Funding Opportunities (Joint Session);
- Regulatory Guidance & Updates (Joint Session);
- Novel Technologies in Stem Cell Research;
- Partnerships & Acquisitions;
- Panel Discussion: Partnerships & Acquisitions;
- Commercialization: Bringing Drug to Market;
- Panel Discussion: Commercialization: Bringing Drug to Market.

Keynote & Featured Speakers Include:
• Glen Prestwich, Presidential Professor, Department of Medicinal Chemistry, University of Utah;
• Douglas Losordo, Vice President, Medical Director, New Therapies, Baxter;
• Leanna Caron, Vice President, Cell Therapy & Regenerative Medicine, Genzyme;
• Devyn Smith, Chief Operating Officer, Neusentis Research Unit, Pfizer;
• Sridaran Natesan, Scientific Site Head & Head, External Innovation & Partnering, Sanofi-Aventis;
• Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute;
• Tiina Palomäki, SWP and CPWP, EMA, & Finnish Medicines Agency;
• Gregory Bonfiglio, Managing Partner, Proteus Venture Partners.

The Stem Cell Summit will also be running concurrently with GTC’s 2nd Diabetes Summit.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Brock Reeve to Present at 8th Stem Cell Summit on April 19-20 in Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  TransPerfect

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)